PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Oner, A.* ; Kobold, S.

Transwell migration assay to interrogate human CAR-T cell chemotaxis.

STAR Protoc. 3:101708 (2022)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
A major impediment to effective cellular therapies in solid tumors is the limited access of therapeutic cells to the tumor site. One strategy to overcome this challenge is to endow T cells with chemotactic properties required to access tumor tissue. Here, we present a chimeric antigen receptor (CAR)-modified T cell strategy centered around enhanced T cell trafficking. We outline isolation, activation, and transduction of human T cells, as well as techniques for assessing migratory and cytotoxic capacity of CAR-T cells. For complete details on the use and execution of this protocol, please refer to Lesch et al. (2021).
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
0.000
0.000
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Biotechnology And Bioengineering ; Cancer ; Cell Isolation ; Cell-based Assays ; Immunology
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
e-ISSN 2666-1667
Zeitschrift STAR Protocols
Quellenangaben Band: 3, Heft: 4, Seiten: , Artikelnummer: 101708 Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Unit for Clinical Pharmacology (KKG-EKLiP)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-522100-001
Förderungen Hector Foundation
International Doctoral Program i-Target: Immunotargeting of Cancer - Elite Network of Bavaria
Melanoma Research Alliance Grants
Else Kroner-Fresenius-Stiftung
German Cancer Aid
Ernst-Jung-Stiftung
LMU Munich's Institutional Strategy LMUexcellent
Marie-Sklodowska-Curie Program Training Network for Optimizing Adoptive T Cell Therapy of Cancer - H2020 Program of the European Union
Go-Bio-initiative
M4 award - Bavarian Ministry of Economic Affairs
European Research Council
German Research Foundation (DFG)
Fritz-Bender Foundation
Wilhelm-Sander-Stiftung
Deutsche Jose-Carreras Leukamie Stiftung
Bundesministerium fur Bildung und Forschung
DOI 10.1016/j.xpro.2022.101708
WOS ID 001062185100007
Scopus ID 85138195219
PubMed ID 36136753
Erfassungsdatum 2022-11-21
[➜Korrektur melden]